Research presented orally at the 44th Congrès International de Langue Française de Médecine Légale et de Médecine Sociale, June 15–18, 2004, Angers, France.
Abusive Prescription of Psychostimulants: A Study of Two Cases
Article first published online: 8 MAR 2006
Journal of Forensic Sciences
Volume 51, Issue 2, pages 407–410, March 2006
How to Cite
Pélissier-Alicot, A.-L., Piercecchi-Marti, M.-D., Bartoli, C., Kuhlmann, E., Coiffait, P.-E., Sanvoisin, A., Giocanti, D. and Léonetti, G. (2006), Abusive Prescription of Psychostimulants: A Study of Two Cases. Journal of Forensic Sciences, 51: 407–410. doi: 10.1111/j.1556-4029.2006.00078.x
- Issue published online: 8 MAR 2006
- Article first published online: 8 MAR 2006
- Received 26 April 2005; and in revised form 1 Aug. 2005 and 14 Oct. 2005; accepted 23 Oct. 2005; published 14 Feb. 2006.
- forensic science;
ABSTRACT: Because psychostimulants have serious possible side effects and particular potential for abuse, their therapeutic indications are today exclusively limited to disorders such as obesity, narcolepsy, or attention deficit/hyperactivity disorder. We report two cases of abusive prescription of these drugs. The first concerns a woman who was treated for a 3 kg weight gain with fenproporex for 5 years and presented a withdrawal syndrome when this drug was no longer marketed in France. In the second case, a woman who complained of atypical sleep problems was prescribed modafinil, methylphenidate, clobazam, lormetazepam, meprobamate, and aceprometazine, and was found dead in her home a few weeks later in unexplained circumstances. For these two patients, neither the indications, nor the contraindications, nor the prescribing rules for these restricted drugs had been complied with. This case report highlights the extreme danger of these substances and stresses the importance of adhering to the rules of prescription.